Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study.

Visco C, Tzankov A, Xu-Monette ZY, Miranda RN, Tai YC, Li Y, Liu WM, d'Amore ES, Li Y, Montes-Moreno S, Dybkær K, Chiu A, Orazi A, Zu Y, Bhagat G, Wang HY, Dunphy CH, His ED, Zhao XF, Choi WW, Zhao X, van Krieken JH, Huang Q, Ai W, O'Neill S, Ponzoni M, Ferreri AJ, Kahl BS, Winter JN, Go RS, Dirnhofer S, Piris MA, Møller MB, Wu L, Medeiros LJ, Young KH

Open source

DOI
10.3324/haematol.2012.066209
Published
2013 Feb
Container
Haematologica
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3324/haematol.2012.066209,
  title = {Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study.},
  author = {Visco C and Tzankov A and Xu-Monette ZY and Miranda RN and Tai YC and Li Y and Liu WM and d'Amore ES and Li Y and Montes-Moreno S and Dybkær K and Chiu A and Orazi A and Zu Y and Bhagat G and Wang HY and Dunphy CH and His ED and Zhao XF and Choi WW and Zhao X and van Krieken JH and Huang Q and Ai W and O'Neill S and Ponzoni M and Ferreri AJ and Kahl BS and Winter JN and Go RS and Dirnhofer S and Piris MA and Møller MB and Wu L and Medeiros LJ and Young KH},
  year = {2013},
  journal = {Haematologica},
  doi = {10.3324/haematol.2012.066209},
  url = {https://doi.org/10.3324/haematol.2012.066209}
}

RIS

TY  - JOUR
TI  - Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study.
AU  - Visco C
AU  - Tzankov A
AU  - Xu-Monette ZY
AU  - Miranda RN
AU  - Tai YC
AU  - Li Y
AU  - Liu WM
AU  - d'Amore ES
AU  - Li Y
AU  - Montes-Moreno S
AU  - Dybkær K
AU  - Chiu A
AU  - Orazi A
AU  - Zu Y
AU  - Bhagat G
AU  - Wang HY
AU  - Dunphy CH
AU  - His ED
AU  - Zhao XF
AU  - Choi WW
AU  - Zhao X
AU  - van Krieken JH
AU  - Huang Q
AU  - Ai W
AU  - O'Neill S
AU  - Ponzoni M
AU  - Ferreri AJ
AU  - Kahl BS
AU  - Winter JN
AU  - Go RS
AU  - Dirnhofer S
AU  - Piris MA
AU  - Møller MB
AU  - Wu L
AU  - Medeiros LJ
AU  - Young KH
PY  - 2013
JO  - Haematologica
DO  - 10.3324/haematol.2012.066209
UR  - https://doi.org/10.3324/haematol.2012.066209
ER  - 

APA

C, V., A, T., ZY, X., RN, M., YC, T., Y, L., WM, L., ES, D., Y, L., S, M., K, D., A, C., A, O., Y, Z., G, B., HY, W., CH, D., ED, H., XF, Z., WW, C., X, Z., JH, V. K., Q, H., W, A., S, O., M, P., AJ, F., BS, K., JN, W., RS, G., S, D., MA, P., MB, M., L, W., LJ, M., & KH, Y. (2013). Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study.. Haematologica. https://doi.org/10.3324/haematol.2012.066209

Source records